Bemarituzumab With Modified Folfox6 For Advanced Fgfr2-Positive Gastroesophageal Cancer: Fight Phase Iii Study Design
2019 · Future Oncology · 67 citations
https://doi.org/10.2217/fon-2019-0141
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
14
Papers
308
Citations
7
h-index
7
i10-index
M.A. Tejani is an academic researcher. The author has contributed to research in topics: Pancreatic and Hepatic Oncology Research & Gastric Cancer Management and Outcomes & Colorectal Cancer Treatments and Studies. The author has an h-index of 7, co-authored 12 publications.
https://doi.org/10.2217/fon-2019-0141
https://doi.org/10.7759/cureus.4713
https://doi.org/10.1213/ane.0000000000007273
Click to start Chat